Background: Estrogen has long been reported to show immunomodulatory effects on immune responses, yet, its specific anti-inflammatory mechanism is not clear. Methods: In this study, we analyzed the effects of β-estradiol (E2), at its contraceptive dose, on both T cell-independent and T cell-dependent inflammations, and the associated immune mechanism, in female mice. The T cell-independent inflammation was locally induced either with an intradermal injection of olive oil in the footpad, or by an intraperitoneal injection of proteose peptone (PP). The T cell-dependent inflammation was induced by an intraperitoneal injection of the purified protein derivatives (PPD). Results: While E2 inhibited olive oil-induced inflammation as monitored by the decrease in footpad swelling, it did not affect the gene expression of monocyte chemoattractant protein-1 and IL-6 by cells at the inflammatory locus. E2 also inhibited PP-induced inflammation as monitored by the decrease in the number of inflammatory peritoneal exudate cells (PEC) coinciding with a marked decrease in the number of macrophages and granulocytes (Gr. 1+). While E2 did not affect the gene expression of monocyte chemoattractant protein-1 and IL-6 by PP-elicited PEC, it decreased both gene expression and production of TNF-α. E2 also decreased the number of cells expressing the lymphocyte function-activated protein-1 in PP-elicited PEC, but not for CD62L. In purified protein derivative-induced T cell-dependent inflammation, E2 decreased the total cellularity of PEC and the relative numbers of CD3+ and CD4+ T cells, and the number of cells expressing the lymphocyte activation markers CD40, CD44, CD69 and IL-2Rα in PEC. Furthermore, while E2 did not affect the gene expression of the early T lymphocyte activation protein-1 by PEC, it decreased the gene expression of INF-γ. Conclusion: Collectively, the results suggest that E2-mediated inhibition of inflammatory responses may be due to a combination of suppression of homing and activation of inflammatory cells and their production of TNF-α and IFN-γ.

1.
Lahita R, Lahita RG: Sex hormones as immunomodulators of diseases. Ann NY Acad Sci 1993;685:278–287.
2.
Holmdahl R, Jansson L, Meyerson B, Klareskog L: Oestrogen induced suppression of collagen arthritis. I. Long-term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response. Clin Exp Immunol 1987;70:372–378.
3.
Bijlsma JW, Van den Brink HR: Estrogens and rheumatoid arthritis. Am J Reprod Immunol 1992;28(3–4):231–234.
4.
Da Silva JAP, Hall GM: The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillière’s Clin Rheumatol 1992;6:196–219.
5.
Okayasu I, Kong YM, Rose NR: Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1981;20:240–245.
6.
Stridgard K: Experimental Allergic Neutritis: Studies on Pathogenesis and Immunoregulation; PhD thesis, Department of Neurology, Karolinska Institute, Stockholm, 1989.
7.
Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowski A: Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 1992;144:190–202.
8.
Klareskog L, Holmdahl R, Larsson E, Wigzell H: Role of T lymphocytes in collagen II-induced arthrithis in rats. Clin Exp Immunol 1983;51:117–125.
9.
Elenkov I, Hoffman J, Wilder RL: Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today 1997;3:379–383.
10.
Josefsson E, Tarkowski A, Carlsten H: Anti-inflammatory properties of estrogen. I. In vivo suppression of leucocyte production in bone narrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992;142:67–78.
11.
Carlsten H, Holmdahl R, Tarkowski A, Nilsson LA: Oestradiol suppression of delayed hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology 1989;67:205–209.
12.
Carlsten H, Holmdahl R, Tarkowski A: Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB×NZW) F1 mice. Immunology 1991;73:186–190.
13.
Carlsten H, Verdrengh M, Taube M: Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice. Inflamm Res 1996;45:26–30.
14.
Kato K, Chen Y, Nakane A, Minagawa T, Fujieda K, Kimura T, Yamamoto K: Suppression of delayed-type hypersensitivity in mice pretreated with diethylstilbesterol: Involvement of sex hormones in immunomodulation. J Leukoc Biol 1988;43:530–538.
15.
Frazier-Jessen MR, Mott FJ, Witte PL, Kovacs EJ: Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation. J Immunol 1996;156:3036–3042.
16.
Salem M: Increase of the bacteriostatic function against early infection of mice with Listeria monocytogenes after treatment with β-estradiol. J Egypt German Soc Zool 1997;23(A):347–378.
17.
Faas MM, Bakker WW, Valkhof N, Schuiling GA: Effect of estradiol and progesterone on the low-dose endotoxin-induced glomerular inflammatory response of the female rat. Am J Reprod Immunol 1999;41:224–231.
18.
Singer SJ: Intracellular communication and cell-cell adhesion. Science 1992;255:1671–1677.
19.
Scollay R, Shortman K: Cell traffic in the adult thymus: Cell entry and exit, cell birth and death; Watson JD, Marbrook J (eds): Recognition and Regulation in Cell-Mediated Immunity. New York, Dekker, 1985, pp 3030–3041.
20.
Yoshimura T, Leonard EJ: Secretion by human fibroblast of monocyte chemoattractant protein-1, the product of gene JE. J Immunol 1990;144:2377–2383.
21.
Zachariae CO, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, Matsushima K: Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 1990;171:2177–2182.
22.
Nau GJ, Guilfoile P, Chupp GL, Berman JS, Kim SJ: A chemoattractant cytokine associated with granulomas on tuberculosis and silicosis. Proc Natl Acad Sci USA 1997;94:6414–6419.
23.
Mackey M, Barth RJ, Noelle RJ: The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 1998;63:418–428.
24.
Bernhagen J, Calandra T, Bucala R: Regulation of the immune response by macrophage migration inhibitory factor: Biological and structural features. J Mol Med 1998;76:151–161.
25.
Cohen JH, Danel L, Cordier G, Saez S, Revillard JP: Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol 1983;131:2767–2771.
26.
Weusten J, Blankenstein MA, Gmelig-Meyling FH, Schuurman HJ, Kater L, Thijssen JH: Presence of estrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol (Copenh) 1986;112:409–414.
27.
Suenaga R, Evans M, Mitamura K, Rider V, Abdou N: Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J Rheumatol 1998;25:1305–1312.
28.
Cocchiara R, Albeggiani G, Trapani DG, Azzolina A, Lampiasi N, Rizzo F, Geraci D: Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens. Int Arch Allergy Appl Immunol 1990;93:192–197.
29.
Gulshan S, McCruden AB, Stimson WH: Oestrogen receptors in macrophages. Scand J Immunol 1990;31:691–697.
30.
Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H: Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun 1993;195:730–736.
31.
Benten WP, Lieberherr M, Giese G, Wunderlich C: Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 1998;422:349–353.
32.
Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 1989;86:2398–2402.
33.
Ralston SH, Russell RG, Gowen M: Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990;5:983–988.
34.
Grasso G, Muscettola M: The influence of β-estradiol and progesterone on interferon gamma production in vitro. Int J Neurosci 1990;51:315–317.
35.
Henriksen O, Frey JR: Control of the expression of interleukin-2 activity. Cell Immunol 1982;73:106–114.
36.
Fox H, Bond LB, Parslow GT: Estrogen regulates the IFN-gamma promoter. J Immunol 1991;146:4362–4367.
37.
Gilmore W, Weiner LP, Correale J: Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997;158:446–451.
38.
Salem ML, Matsuzaki G, Madkour G, Nomoto K: β-Estradiol-induced decrease in IL-12 and TNF-α expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice. Int J Immunopharmacol 1999;21:481–497.
39.
Cybulsky MI, Gimbrone MA: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788–791.
40.
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer L, Edwards PA, Watson AD, Lusis AJ: Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics. Circulation 1995;91:2488–2496.
41.
Koh KK, Bui MN, Mincemoyer R, Cannon RO: Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women. Am J Cardiol 1997;80:1505–1507.
42.
Keisler LW, Walker SE: Suppression of reproductive function in autoimmune NZB/W mice: Effective doses of four contraceptive steroids. Am J Reprod Immunol Microbiol 1987;14:115–121.
43.
Czuprynski CP, Henson M, Campbell PA: Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol 1984;35:193–208.
44.
Chomczynski P, Sachi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biochem 1987;162:156–159.
45.
Brick JE, Wilson DA, Walker SE: Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/W mice. J Immunol 1985;134:3693–3698.
46.
Dahlgren UI, Hanson LA: Effect of estradiol on the secretory immune system in the rat: An increase in biliary IgM antibodies against a T-cell independent antigen. Immunology 1991;74:74–77.
47.
Diaz-Gonzalez F, Sanchez-Madrid F: Inhibition of leukocyte adhesion: An alternative mechanism of action for anti-inflammatory drugs. Immunol Today 1998;19:169–172.
48.
Buyon JP, Korchak HM, Rutherford LE, Ganguly M, Weissmann G: Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum 1984;27:623–630.
49.
Ito I, Hayashi T, Yamada K, Kuzuya M, Naito M, Iguchi A: Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system. Life Sci 1995;56:2247–2253.
50.
Frazier-Jessen MR, Kovacs EJ: Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995;154:1838–1845.
51.
Kovacs EJ, Faunce DE, Ramer-Quinn DS, Mott FJ, Dy WP, Frazier-Jessen MR: Estrogen regulation of JE/MCP-1 mRNA expression in fibroblasts. J Leukoc Biol 1996;59:562–568.
52.
Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD: Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 1997;38:46–54.
53.
Phadke K, Carlson DG, Gitter BD, Parente L: Role of IL-1 and IL-2 in rat and mouse arthritis models. J Immunol 1986;136:4085–4091.
54.
Saito S, Foegh M, Motomura N, Lou H, Kent K, Ramwell PW: Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression. Transplantation 1998;66:1424–1431.
55.
Shirai M, Sato A, Chida K: The influence of ovarian hormones on the granulomatous inflammatory process in the rat lung. Eur Respir J 1995;8:272–277.
56.
Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ: Antibody to the ligand of CD40, gp 39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 1994;94:1333–1338.
57.
Noelle RJ: CD40 and its ligand in host defence. Immunity 1996;4:415–419.
58.
DeGrendele HC, Estess P, Siegelman MH: Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672–675.
59.
Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C: Regulatory CD4 T cells: Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998;10:371–378.
60.
Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749–795.
61.
Ahmed A, Talal N: Sex hormones and the immune system. Part 2. Animal data. Baillière’s Clin Rheumatol 1990;4:13–31.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.